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Abstract
Autophagy is a bulk degradation mechanism for cytosolic proteins and organelles. The heart undergoes hypertrophy in
response to mechanical load but hypertrophy can regress upon unloading. We hypothesize that autophagy plays an
important role in mediating regression of cardiac hypertrophy during unloading. Mice were subjected to transverse aortic
constriction (TAC) for 1 week, after which the constriction was removed (DeTAC). Regression of cardiac hypertrophy was
observed after DeTAC, as indicated by reduction of LVW/BW and cardiomyocyte cross-sectional area. Indicators of
autophagy, including LC3-II expression, p62 degradation and GFP-LC3 dots/cell, were significantly increased after DeTAC,
suggesting that autophagy is induced. Stimulation of autophagy during DeTAC was accompanied by upregulation of
FoxO1. Upregulation of FoxO1 and autophagy was also observed in vitro when cultured cardiomyocytes were subjected to
mechanical stretch followed by incubation without stretch (de-stretch). Transgenic mice with cardiac-specific
overexpression of FoxO1 exhibited smaller hearts and upregulation of autophagy. Overexpression of FoxO1 in cultured
cardiomyocytes significantly reduced cell size, an effect which was attenuated when autophagy was inhibited. To further
examine the role of autophagy and FoxO1 in mediating the regression of cardiac hypertrophy, beclin1+/2 mice and
cultured cardiomyocytes transduced with adenoviruses harboring shRNA-beclin1 or shRNA-FoxO1 were subjected to TAC/
stretch followed by DeTAC/de-stretch. Regression of cardiac hypertrophy achieved after DeTAC/de-stretch was significantly
attenuated when autophagy was suppressed through downregulation of beclin1 or FoxO1. These results suggest that
autophagy and FoxO1 play an essential role in mediating regression of cardiac hypertrophy during mechanical unloading.
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Introduction
The postnatal heart undergoes hypertrophy in response to
mechanical overload, which can be induced by high blood
pressure or a partial loss of myocardial tissue after myocardial
infarction. Cardiac hypertrophy is characterized by the
enlargement of individual cardiomyocytes, expression of fetal-
type genes, and cytoskeletal reorganization [1]. Although
cardiac hypertrophy is an important adaptation of the heart in
response to increased wall stress, the continued presence of
hypertrophy leads to myocardial cell death and cardiac
dysfunction, and thus, hypertrophy is believed to be a significant
risk factor for the development of heart failure [2]. Importantly,
however, cardiac hypertrophy can be reversed when the
increased wall stress is normalized, a process termed regression.
Unloading of hemodynamic stress by a left ventricular assist
device induces regression of cardiac hypertrophy and improve-
ment of LV function in end-stage heart failure patients [3].
Regression of cardiac hypertrophy is accompanied by activation
of unique sets of genes, including fetal-type genes and those
involved in protein degradation [4,5]. However, the signaling
mechanism mediating regression of cardiac hypertrophy has
been poorly understood.
Macroautophagy (hereafter autophagy) is a bulk degradation
process for cytosolic proteins and organelles mediated through the
formation of double membranous vesicles, termed autophago-
somes, fusion of autophagosomes with lysosomes, and degradation
by the lysosomal acid hydrolases and proteases [6]. Autophagy is
an important mechanism of catabolism for maintaining cellular
homeostasis during energy deprivation, while it also contributes to
the quality control of proteins and organelles during stress.
Although cardiac hypertrophy is often accompanied by
increases in protein synthesis, it is also accompanied by structural
remodeling and dysfunction of intracellular organelles. One of the
cellular mechanisms for adaptation against these during cardiac
hypertrophy could be activation of autophagy. In fact, autophagy
is activated during acute and chronic phases of cardiac hypertro-
phy [7,8]. Although the functional significance of autophagy
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e51632
during cardiac hypertrophy is not fully understood, autophagy
may promote clearance of damaged proteins and organelles.
Considering that regression of cardiac hypertrophy is the reverse
process of hypertrophy, regression of cardiac hypertrophy may
also influence autophagy.
The forkhead box, class O (FoxO) family transcription factors
are critical regulators of autophagy in cardiomyocytes [9,10].
They are also involved in regulating muscle atrophy in skeletal
muscle via the activation of protein degradation mechanisms
including autophagy and the ubiquitin proteasome system
[11,12,13]. While FoxOs also negatively regulate hypertrophy in
the heart [14,15], whether FoxOs are directly involved in
regression of cardiac hypertrophy and, if so, the precise
mechanism through which FoxOs mediate regression of cardiac
hypertrophy are unknown.
In this study, we used transverse aortic constriction followed by
de-constriction as a model to study the mechanism mediating
regression of cardiac hypertrophy. The goals of this study were to
1) elucidate the role of autophagy during regression of cardiac
hypertrophy, and 2) understand the role of FoxO1 in mediating
regression of cardiac hypertrophy. We here report that autophagy
plays an important role in mediating regression of cardiac
hypertrophy in response to mechanical unloading and that FoxO1




Antibodies used in the study include those against LC3 (MBL,
#PD014), p62 (ARP, #03-GP62-C), FoxO1 (Epitomics, #1874-1
& Cell Signaling, #9454), Beclin1 (BD Biosciences, #612112),
Cathepsin L (Sigma-Aldrich, #C2970), Sirt1 (Upstate, #07-131),
P-AMPKa (Cell signaling, #2535), AMPK (Cell Signaling,
#2532), Rab7 (Sigma-Aldrich, #R4779) and a-Tubulin (Sigma-
Aldrich #T6199).
Microsurgery for pressure overload & unloading
The method of inducing pressure overload by TAC has been
described previously [16]. To induce unloading of myocytes, the
suture in the aortic arch was removed 1 week after TAC (DeTAC)
and the mice were observed for 7 days, after which they were
subjected to echocardiography and hemodynamic analyses and
sacrificed. All protocols concerning animal use were approved by
the Institutional Animal Care and Use Committee at the
University of Medicine and Dentistry of New Jersey.
Transgenic mice
Transgenic mice with cardiac-specific overexpression of WT-
FoxO1 (Tg-FoxO1) were generated on an FVB background using
the murine a-myosin heavy chain promoter provided kindly by
Dr. J Robbins (University of Cincinnati, Cincinnati). The plasmid
harboring WT-FoxO1 was a kind gift from Dr. Domenico Accili
(Columbia University, New York) [17]. Transgenic mice express-
ing GFP-LC3 (Tg-GFP-LC3) [18,19], Beclin1 heterozygous
knockout mice (beclin1+/2) [18] and FoxO1 cardiac-specific
homozygous knockout mice (c-FoxO12/2) [9] have been
described previously. Double transgenic or bigenic Tg-FoxO1
and Tg-GFP-LC3 mice were generated by breeding, and only F1
generation mice were used for evaluation of GFP-LC3 puncta.
Echocardiography analyses
The method used to analyze cardiac function using echocar-
diography in mice has been described previously [9,20].
Primary culture of neonatal rat ventricular myocytes
Primary cultures of left ventricular cardiomyocytes were
prepared from 1-day-old Crl: (WI) BR-Wistar rats (Harlan
Laboratories) as described previously [9,18]. A fraction enriched
for cardiomyocytes (.95%) was obtained by centrifugation
through a discontinuous Percoll gradient [18].
Adenoviruses
Adenoviruses harboring WT-FoxO1 (Ad-FoxO1-WT), short
hairpin (sh-) FoxO1 (Ad-sh-FoxO1), sh-scramble (Ad-sh-Scr),
control LacZ (Ad-LacZ) [9], and sh-Beclin1 (Ad-sh-Beclin1)
[9,18] have been described previously. Myocytes were transduced
with 15 MOI of adenoviruses. Ad-LacZ and Ad-FoxO1-WT
transductions were carried out for 24 hours, while Ad-sh-Scr, Ad-
sh-FoxO1 and Ad-sh-Beclin1 were transduced for 96 hours.
Evaluation of cell size
To evaluate cardiomyocyte cross-sectional area in vivo, tissue
sections of mouse hearts were fixed in 10% neutral-buffered
formalin, embedded in paraffin, sectioned at 5 mm thickness and
stained with wheat germ agglutinin Texas red, as described
previously [20]. The outlines of at least 200 circular to oval shaped
myocytes with nearly circular capillary profiles were traced in 10
fields from 3 different mouse samples and the cross-sectional area
was measured using Image-Pro Plus software (Media Cybernetics).
To determine cell size in vitro, images of cultured cardiomyocytes
were obtained at 206magnification using a light microscope. The
outlines of cardiomyocytes obtained in 8 different visual fields from
at least 3 different cultures were traced and the relative cross-
sectional area was evaluated.
Evaluation of fluorescent LC3 puncta
The method used to evaluate fluorescent LC3 puncta in vivo has
been described previously [9,18]. Briefly, fresh heart slices were
embedded with Tissue-Tek OCT compound (Sakura Finetechni-
cal Co., Ltd.) and frozen at 270uC. Sections 10-mm-thick were
obtained from the frozen tissue samples using a cryostat (CM3050
S, Leica), air-dried for 30 min, fixed by washing in 95% ethanol
for 10 minutes, mounted using a reagent containing 49,6-
diamidino-2-phenylindole (DAPI) (Vectashield; Vector Laborato-
ries Inc.) and viewed under a fluorescence microscope (Nikon
Eclipse E800). The number of GFP-LC3 dots was determined by
manual counting in 10 fields from 5 different animals using a 606
objective, and nuclear number was evaluated by counting DAPI-
stained nuclei in the same fields using the same magnification. The
number of GFP-LC3 puncta/cell was evaluated as the total
number of dots divided by the number of nuclei in each
microscopic field.
Sample preparation and immunoblot analysis
Heart tissue homogenates were prepared using RIPA buffer,
while protein lysates from cultured cardiomyocytes were prepared
using boiled 26 SDS sample buffer, as has been described
previously [9]. To evaluate protein concentration in cultured
myocytes, RIPA buffer with lysosomal protease inhibitors (1:200
dilution) was used to extract proteins. The method used to detect
protein expression using immunoblots has been described
previously [9,18]. Densitometric analyses of the blots were carried
out using the public domain ImageJ program (NIH, Maryland).
Quantitative reverse transcription-PCR
Total RNA was extracted from mouse hearts and in vitro cultures
using TRIzol (Invitrogen). cDNA was synthesized using the
Autophagy Induces Cardiac Hypertrophy Regression
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RETROscript kit (Ambion) according to the manufacturer’s
instructions. Real time-PCR was carried out as stated previously
[20]. Primers for Gabarapl1 [11,13], Bnip3 [11], Ulk2 [13], and
ANF [20] have been reported previously. The following primer
pairs were also used –
FoxO1: Sense – CAGATCTACGAGTGGATGGT
FoxO1: Antisense – ACTTGCTGTGTAGGGACAGA
GAPDH: Sense – GAGCTGAACGGGAAGCTCACT
GAPDH: Antisense – TTGTCATACCAGGAAATGAGC
In vitro model of hypertrophy regression
Neonatal rat ventricular myocytes were cultured in collagen-I-
coated BioFlex plates (Flexcell Intl, #BF-3001C) and subjected to
20% cyclic stretch in a uniaxial strain at 30 cycles/min for
36 hours in a 37uC incubator. Myocytes subjected to mechanical
stretch and incubation without stretch for 36 hours each were
considered a de-stretch model. Control samples were cultured in
the Bioflex plates without going through the stretch regimen.
Autophagy Inhibitors
To inhibit autophagosome formation, cultured cardiomyocytes
were treated with 10 mM 3-Methyladenine (3-MA) for 24 hours
or Ad-sh-Beclin1 for 72 hours as described [18]. To inhibit
autophagy flux in vivo, chloroquine was injected (10 mg/kg)
intraperitoneally for 4 hours as previously described [21], follow-
ing which animals were euthanized to detect expression of
autophagy markers by immunoblot.
Statistics
Data are expressed as mean 6 SEM. Statistical analyses
between groups of 2 were done by unpaired t-test. Groups of 3 or
more were analyzed using one-way ANOVA, followed by the
Newman-Keuls multiple comparison test. A value of p,0.05 was
considered significant.
Ethics Statement
All animal protocols were approved by the review board of the
Institutional Animal Care and Use Committee of the University of
Medicine and Dentistry of New Jersey (07115 and 10073).
Results
Left ventricular unloading induces regression of cardiac
hypertrophy
To study the involvement of autophagy in the regression of
cardiac hypertrophy, C57BL/6 mice were subjected to pressure
overload caused by transverse aortic constriction for 1 week (1W
TAC), after which unloading was induced by removal of the
constriction for 1 week (1W DeTAC). After 1W TAC, cardiac
hypertrophy was observed via echocardiographic and postmortem
analyses, as indicated by significant increases in LV weight
(LVW)/body weight (BW) (Fig. 1A), and diastolic septal and
posterior wall thickness (Fig. 1BC). After 1W DeTAC, a significant
decrease in cardiac mass was observed, indicating regression
(Fig. 1ABC). Left ventricular ejection fraction (LVEF) was
decreased slightly after 1W TAC compared to sham (Fig. 1D
and Supplemental Table S1), but did not decrease further after
1W DeTAC (Fig. 1D). The mRNA level of atrial natriuretic factor
(ANF), a fetal-type gene reactivated during cardiac hypertrophy,
was increased significantly after 1W TAC and was decreased after
1W DeTAC (Fig. 1E). Histological analyses showed that LV
myocyte cross-sectional area was increased after 1W TAC,
whereas it was significantly and uniformly reduced after 1W
DeTAC compared to after 1W TAC (Fig. 1FG and supplemental
Fig. S1), again indicating regression of cardiac hypertrophy.
Autophagy is enhanced during regression of cardiac
hypertrophy
We hypothesized that autophagy is activated during regression
of cardiac hypertrophy. Expression of LC3-II, a protein known to
be associated with autophagosomes, was increased following 1W
DeTAC (Fig. 2AB). To evaluate the extent of autophagosome
formation upon regression of cardiac hypertrophy, we examined
transgenic mice harboring GFP-LC3 (Tg-GFP-LC3) [19] and
found that the number of GFP-LC3 dots/cell was significantly
increased upon cardiac unloading (Fig. 2CD). Expression of p62, a
polyubiquitin-binding protein sequestered in autophagosomes for
lysosomal degradation [22], was significantly reduced in DeTAC
samples, indicating increased autophagic flux during regression of
cardiac hypertrophy (Fig. 2AB). Collectively, these results suggest
that autophagy is significantly induced during regression of cardiac
hypertrophy. Interestingly, although the number of GFP-LC3
dots/cell was increased significantly, LC3-II was decreased and
p62 was accumulated after 1W TAC. These results suggest that
autophagic flux might be inhibited after 1W TAC under our
experimental conditions (Fig. 2AB).
FoxO1 is involved in mediating regression of cardiac
hypertrophy
There are several reports describing the role of FoxO
transcription factors in muscle atrophy [12,13,14,15]. We and
others have shown previously that FoxO1 is a critical regulator of
autophagic flux in cardiomyocytes [9,10]. Thus, we hypothesized
that FoxO1 may be involved in mediating the reduction in cardiac
mass and cell size during regression of cardiac hypertrophy. To
this end, we evaluated expression of FoxO1 after 1W TAC and
1W DeTAC. FoxO1 was significantly upregulated during
regression of cardiac hypertrophy, while it was downregulated
during cardiac hypertrophy (Fig. 2AB).
FoxO1 regulates autophagy in vivo
To elucidate the role of FoxO1 in mediating autophagy in the
heart in vivo, we generated transgenic mice with cardiac-specific
overexpression of WT-FoxO1 (Tg-FoxO1). We generated two
lines of transgenic mice (lines #8 and #36) with different levels of
FoxO1 expression (3.7- and 11.9-fold increase, respectively,
relative to non-transgenic (NTg) mice) (Fig. 3AB). Both lines
showed decreased cardiac mass, as evidenced by the significantly
smaller size of the LV and the cardiomyocytes therein (Supple-
mental Fig. S2). In order to examine the effect of FoxO1
upregulation upon autophagy in vivo, we evaluated expression of
several autophagy markers in Tg-FoxO1 mice (Line #8). mRNA
levels of Gabarapl1, Bnip3, and Ulk2, genes associated with
autophagosome formation [11,13], were significantly increased in
Tg-FoxO1 mice (Fig. 3C). Protein expression of autophagy
markers and molecules known to regulate autophagy, including
LC3-II accumulation, p62 degradation, Beclin1, Cathepsin L,
Sirt1, P-AMPKa and Rab7, was significantly increased in Tg-
FoxO1 mice (Fig. 3DE). To evaluate autophagosome formation,
we generated bigenic mice (Tg-GFP-LC3-FoxO1) by breeding Tg-
FoxO1 and Tg-GFP-LC3 mice. The number of GFP-LC3 dots/
cell was significantly greater in the bigenic mice than in Tg-GFP-
LC3 mice (Fig. 3FG), indicating that FoxO1 can increase
autophagosome formation. Chloroquine treatment (10 mg/kg
IP) further increased the level of LC3-II in Tg-FoxO1 as
determined by immunoblot analyses (Supplemental Fig. S3).
Autophagy Induces Cardiac Hypertrophy Regression
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Figure 1. Left ventricular unloading induces regression of cardiac hypertrophy. C57BL/6 mice were subjected to pressure overload caused
by thoracic aortic constriction for 1 week (1W TAC), followed by cardiac unloading by removal of the constriction for 1 week (1W DeTAC). A) Left
ventricular weight/body weight (LVW/BW). B) Diastolic septal wall thickness (DSEP WT), C) diastolic posterior wall thickness (DPW WT), and D) left
ventricular ejection fraction (LVEF), as evaluated by echocardiographic analyses. E) mRNA level of atrial natriuretic factor (ANF), evaluated by qRT-PCR.
Autophagy Induces Cardiac Hypertrophy Regression
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Together with the decreased expression of p62 (Fig. 3DE), these
results suggest that FoxO1 positively regulates autophagy and
autophagosome formation in the heart.
Treatment with autophagy inhibitors attenuates FoxO1–
induced reduction in cell size
To determine the role of FoxO1 and autophagy in cell size
regulation, cultured cardiomyocytes were transduced with an
adenovirus harboring WT-FoxO1 (Ad-FoxO1-WT) and treated
with known inhibitors of autophagy, 3-methyladenine (3-MA), an
inhibitor of class III phosphatidyl inositol -3 kinase (PI3K), or an
adenovirus harboring shRNA-Beclin1 (Ad-sh-Beclin1), as de-
scribed previously [18]. Overexpression of FoxO1 induced
autophagy, as seen by p62 degradation (Fig. 4AB), which was
significantly attenuated by treatment with 3-MA and Ad-sh-
Beclin1 transduction (Fig. 4AB), confirming that 3-MA and Ad-sh-
Beclin1 can inhibit FoxO1-induced increases in autophagy. Under
these experimental conditions, Ad-FoxO1-WT reduced the
cardiomyocyte size (Fig. 4CD) and the relative protein content
(Fig. 4E) significantly, while inhibition of autophagy attenuated
both of these FoxO1-induced reductions (Fig. 4CDE). Collectively,
these results indicate that FoxO1 reduces the size of cardiomy-
ocytes and that autophagy plays an important role in mediating
FoxO1-induced decreases in the cell size of cardiomyocytes.
FoxO1 expression and autophagy are increased in an in
vitro model of regression of cardiac hypertrophy
To better understand the role of FoxO1 in mediating regression
of cardiac hypertrophy, we created an in vitro model of regression
of cardiac hypertrophy in which cardiomyocytes were cultured in
collagen-I-coated special culture dishes, subjected to repetitive
mechanical stretch for 36 hours and subsequently incubated
Figure 2. Autophagy and FoxO1 expression are upregulated during regression of cardiac hypertrophy. Control C57BL/6 and Tg-GFP-
LC3 mice were subjected to sham, 1W TAC and 1W DeTAC surgeries. A) Representative immunoblots of autophagy markers and FoxO1 from mouse
hearts. B) Densitometric analyses. C) Representative images of fluorescent LC3 puncta in hearts from Tg-GFP-LC3 mice. Arrows indicate LC3 puncta.
D) Mean number of GFP-LC3 dots/cell. Data represent means from at least 3 mice each. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0051632.g002
F) Representative images of transverse sections of the LV after wheat germ agglutinin staining. G) Cross-sectional area of myocytes (in mm2). N = at
least 8 mice in each group. * p,0.05, ** p,0.01, N.S.: Not Significant.
doi:10.1371/journal.pone.0051632.g001
Autophagy Induces Cardiac Hypertrophy Regression
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Figure 3. Overexpression of FoxO1 regulates autophagy in vivo. Transgenic mice with cardiac-specific overexpression of WT-FoxO1 (Tg-
FoxO1) were generated. A) Representative immunoblots comparing FoxO1 expression levels in the two lines (lines #8 and #36) of Tg-FoxO1 and
nontransgenic (NTg) mice. B) Densitometric analyses. C) mRNA levels of autophagy genes Gabarapl1, Bnip3 and Ulk2. D) Representative immunoblots
of autophagy markers. E) Densitometric analyses. F–G) Tg-FoxO1 mice were bred with Tg-GFP-LC3 to generate Tg-GFP-LC3 – FoxO1 bigenic mice. F)
Representative images of GFP-LC3 puncta. Arrows indicate LC3 puncta. G) Mean number of GFP-LC3 dots/cell. Data represent means from at least 4
individual mice. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0051632.g003
Autophagy Induces Cardiac Hypertrophy Regression
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Figure 4. Autophagy inhibition attenuates FoxO1-induced reduction in cell size and relative protein content. Cultured cardiomyocytes
were transduced with Ad-FoxO1-WT or Ad-LacZ for 24 hours or Ad-sh-Beclin1 for 96 hours, and treated with 10 mM 3-methyladenine (3-MA) for
24 hours. A) Representative immunoblots. B) Densitometric analyses. C) Representative images of cardiomyocytes viewed under a light microscope.
Autophagy Induces Cardiac Hypertrophy Regression
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without stretch (de-stretch) for the same length of time (Fig. 5A).
The relative protein content and the mRNA level of ANF were
significantly increased following mechanical stretch, indicating
induction of cardiac hypertrophy, but were attenuated after de-
stretch, indicating regression of cardiac hypertrophy (Fig. 5BC).
FoxO1 mRNA (Fig. 5D) and protein expression levels (Fig. 5EF)
were significantly increased after de-stretch. Autophagy was also
enhanced during de-stretch, as indicated by increased LC3-II and
decreased p62 expression (Fig. 5EF). Taken all together, these
results indicate that FoxO1 and autophagy may contribute to
regression of cardiac hypertrophy in vitro.
Absence of FoxO1 and autophagy attenuates the extent
of regression of cardiac hypertrophy in vitro and in vivo
To show that autophagy is required for mediating regression of
cardiac hypertrophy, we subjected beclin1+/2 mice to regression
of cardiac hypertrophy. Autophagy was significantly suppressed in
beclin1+/2 mice after 1W DeTAC, as indicated by increased p62
expression, relative to control mice subjected to 1W DeTAC
(Fig. 6AB). In the absence of autophagy, the extent of regression of
cardiac hypertrophy was attenuated, as indicated by the significant
reduction in LVW/BW after DeTAC in control mice, but not in
beclin1+/2 mice and the decreased % regression of cardiac
hypertrophy (which is the percentage decrease in LVW/BW
values after 1W DeTAC compared to after 1W TAC alone)
(Supplemental Fig. S4) in beclin1+/2 mice. Similarly, in the
absence of autophagy in vitro due to knock-down of Beclin1 using
Ad-sh-Beclin1, the % regression of cardiac hypertrophy (which is
the percentage reduction in relative protein content after de-
stretch compared to stretch alone) was significantly attenuated
(Fig. 6D). This confirmed that autophagy is required for regression
of cardiac hypertrophy. To determine whether FoxO1 is required
to mediate regression of cardiac hypertrophy, we used an
adenovirus harboring sh-FoxO1 (Ad-sh-FoxO1), which has been
described previously [9]. The absence of FoxO1 significantly
decreased the extent of regression of cardiac hypertrophy in vitro
(Fig. 6D). Taken all together, this suggests that endogenous FoxO1
is required for mediating regression of cardiac hypertrophy,
possibly through stimulation of autophagy (Fig. 6E).
Discussion
We here show that a) regression of cardiac hypertrophy is
induced by left ventricular unloading and de-stretch of cultured
cardiomyocytes after mechanical stretch, and is accompanied by
increased autophagy and upregulation of FoxO1, b) FoxO1
increases the expression of autophagy genes and autophagosome
formation in mouse hearts in vivo, c) overexpression of FoxO1
reduces cardiomyocyte size, whereas inhibition of autophagy
attenuates FoxO1-induced reductions in cell size and protein
content, and d) autophagy and FoxO1 are required to mediate
regression of cardiac hypertrophy both in vitro and in vivo.
Upregulation of FoxO1 is sufficient to stimulate autophagy in
cardiomyocytes in vitro, as shown in our previous study [9], and in
vivo, as shown in this study. We and others have shown previously
that FoxO3 also stimulates autophagy in cardiomyocytes [9,10]. In
addition, both FoxO1 and FoxO3 negatively regulate cardiac
hypertrophy [14]. Thus, we do not exclude the role of FoxO3,
another major isoform of the FoxO family expressed in the heart,
in mediating autophagy and consequently mediating regression of
cardiac hypertrophy by DeTAC or destretch. However, down-
regulation of FoxO1 significantly attenuated DeTAC- and de-
stretch-induced regression of cardiac hypertrophy, suggesting that
FoxO1 may have non-overlapping functions compared to FoxO3
that induce regression of cardiac hypertrophy.
Cardiac hypertrophy induced by pressure overload or mechan-
ical stretch is accompanied by activation of Akt through
phosphatidylinositol 3 kinase. Akt phosphorylates FoxOs, thereby
inducing their cytosolic translocation, which may remove the
FoxOs’ negative constraint upon hypertrophy and, thus, induce
cardiac hypertrophy [15]. We here demonstrate that protein
expression of FoxO1 is upregulated in response to DeTAC or de-
stretch and that endogenous FoxO1 is required for regression of
cardiac hypertrophy. Whether posttranslational modifications of
FoxOs, such as dephosphorylation and deacetylation, are required
for activation of autophagy and consequent regression of cardiac
hypertrophy remains to be investigated.
FoxO proteins are critical regulators of protein degradation
mechanisms, including the autophagy-lysosome pathway and the
ubiquitin proteasome system. Although we showed the involve-
ment of the former in mediating regression of cardiac hypertrophy
after DeTAC here, at present, FoxO1-mediated upregulation of
atrogin-1/MAFbx, a muscle-specific E3 ubiquitin ligase [12], and
its involvement in regression of cardiac hypertrophy after DeTAC
cannot be excluded. Increasing lines of evidence suggest that
functional interactions exist between autophagy and the ubiquitin
proteasome system [23]. For example, degradation of ubiquiti-
nated protein by the lysosome may occur through autophagy, with
interaction with p62 leading to the ubiquitinated protein being
engulfed by autophagosomes.
Overexpression of FoxO1 in the heart markedly reduces cardiac
mass and cardiomyocyte size in transgenic mice. It has been
shown that FoxO3 negatively regulates cell cycle/proliferation,
thereby inhibiting normal growth of the heart during development
[24]. We speculate that the small heart observed in our Tg-FoxO1
may be caused by multiple mechanisms activated through
persistent upregulation of FoxO1 in postnatal hearts.
The molecular mechanism through which activation of
autophagy contributes to regression of cardiac hypertrophy
remains to be elucidated. For example, activation of autophagy
may allow cardiomyocytes to degrade substantial amounts of
proteins and damaged organelles. However, contributions of total
proteins degraded by the lysosome to the total level of hypertrophy
regression remain to be elucidated. It is formally possible that
autophagy may contribute to hypertrophy regression through
degradation of signaling molecules or key regulators of protein
synthesis/degradation. We show that autophagy may be sup-
pressed by stretch and 1W TAC. However, suppression of
autophagy alone may not be sufficient to induce cardiac
hypertrophy since some loss-of-function mouse models of autoph-
agy, including beclin1+/2 mice, do not exhibit cardiac hypertro-
phy at baseline, at least at a young age. Thus, further research is
necessary to clarify the molecular mechanism through which
autophagy regulates development and regression of cardiac
hypertrophy.
In this model, we were not able to extend the period of the
initial TAC sufficiently long enough for the mouse to develop
heart failure since the longer TAC facilitated scar formation in the
area of constriction and prevented the removal of the pressure
gradient. Thus, in order to investigate how regression of cardiac
D) Relative cardiomyocyte cross-sectional area. E) Relative protein content. Data represent means from at least 6 different myocyte cultures. * p,0.05,
** p,0.01.
doi:10.1371/journal.pone.0051632.g004
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Figure 5. FoxO1 expression and autophagy are increased in an in vitro model of regression of cardiac hypertrophy. Cardiomyocytes
were cultured in BioFlex plates, subjected to mechanical cyclic stretch for 36 hours (Stretch) and incubated without stretch for 36 hours (de-stretch).
A) Scheme showing the regimen of mechanical stretch and de-stretch. B) Relative protein content. C–D) mRNA levels of ANF and FoxO1, determined
by qRT-PCR. E) Representative immunoblots. F) Densitometric analyses. Data represent means from at least 4 different myocyte cultures. * p,0.05, **
p,0.01.
doi:10.1371/journal.pone.0051632.g005
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Figure 6. FoxO1 and autophagy are required for regression of cardiac hypertrophy. Control C57BL/6 mice and mice with heterozygous
knockout of Beclin1 (beclin1+/2) were subjected to 1W TAC and 1W DeTAC surgeries. A) Representative immunoblots. B) Densitometric analyses. C)
Left ventricular weight/body weight (LVW/BW). D) Cultured cardiomyocytes were transduced with Ad-sh-Scr, Ad-sh-Beclin1 and Ad-sh-FoxO1 and
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hypertrophy mediated through autophagy affects LV function,
improvement of the animal model appears to be essential.
Supporting Information
Figure S1 Distribution of cardiomyocyte cell size in mice after
TAC and DeTAC. C57BL/6 mice were subjected to pressure
overload caused by thoracic aortic constriction for 1 week (1W
TAC), followed by cardiac unloading by removal of the
constriction for 1 week (1W DeTAC). Size distribution of cardiac
myocyte cross- sectional area was measured from at least 50 cells
from 3 different animals in each group.
(TIF)
Figure S2 Characterization of Tg-FoxO1. Cardiac phenotype of
Tg-FoxO1 (line #8). Tg-FoxO1 and non-transgenic (NTg) mice
were euthanized at the age of 3 months. A) Pictures of NTg and
Tg-FoxO1 (line #8) hearts. Each graduation in the scale
below = 1 mm. B) Left ventricular weight (LVW)/body weight
(BW) (mg/g). n = 32. C,D) LV cardiomyocyte cross sectional area.
Wheat germ agglutinin staining was performed and average
cardiomyocyte cross sectional area was obtained in NTg and Tg-
FoxO1 hearts.
(TIF)
Figure S3 Stimulation of autophagy in Tg-FoxO1 hearts. Tg-
FoxO and NTg mice were treated with chloroquine (Chq, 10 mg/
kg, ip), and euthanized 4 hours after treatment. A. Immunoblots
showing FoxO1, LC3 and tubulin in the heart. The level of a-
tubulin is shown as a loading control. B. Densitometric analyses for
LC3-II expression. The data are mean of two experiments.
(TIF)
Figure S4 Regression of cardiac hypertrophy was blunted in
beclin1+/2 mice. Control C57BL/6 mice and transgenic mice
with heterozygous knockout of Beclin1 (beclin1+/2) were subjected
to 1W TAC and 1W DeTAC surgeries. Percentage decrease in
LVW/BW values after 1W TAC and 1W DeTAC compared to
after 1W TAC alone is represented as % regression of cardiac
hypertrophy in vivo. **p,0.01.
(TIF)
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subjected to mechanical stretch/de-stretch. The percentage reduction in relative protein content after de-stretch compared to after stretch is
represented as % regression of cardiac hypertrophy in vitro. E) A scheme showing the proposed hypothesis of this study. * p,0.05, ** p,0.01, N.S.:
Not Significant.
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